1. Scrip
  2. >>COVID-19

Coronavirus Update: Storage Boost For Pfizer/BioNTech, More Positive Data For Regeneron Antibody Cocktail

 
• By Scrip Team

The approved fridge storage time for Pfizer and BioNTech's Comirnaty has been extended to a month, Regeneron's scores with low-dose REGEN-COV, an early win for GSK and CureVac's next-generation mRNA vaccine and more orders of the AstraZeneca vaccine benefits Oxford Biomedica's bank balance.  

Pfizer package
Storage solution for Pfizer/Biontech vaccine • Source: Alamy

The approved fridge storage time for Pfizer Inc. and BioNTech SE's mRNA-based COVID-19 vaccine Comirnaty has been extended from just five days to one month, following a guidance change by the European Medicines Agency.

The previous advice from the agency stated that the vaccine had to be kept at an ultra-cold temperature, between -70C and -80C, until a few days before use when it could be transferred to a standard medical fridge

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from COVID-19

More from Scrip

Lupin CEO On Trump’s Most Favored Nation Policy, Tariffs, Firm’s Five-Year Plan

 
• By Vibha Ravi

Lupin CEO Vinita Gupta speaks on Trump’s most favored nation policy, the Inflation Reduction Act’s “pill penalty” and other developments in the US, a major market for the company. The company also outlines a five-year plan focused on complex generics and technology platforms.

Novo Nordisk’s CEO Forced Out After Falling Behind In GLP-1 Battle

 
• By Andrew McConaghie

Company surprises investors with Jørgensen's exit but insists its strategy will not change.

In Brief: US FDA Delay Sends Biohaven Shares Down

 
• By Andrew McConaghie

The US regulator’s decision has taken Biohaven and investors by surprise, with the reason for a ‘major amendment’ status not clear.